Asklepion Pharmaceuticals Overview
- Founded
- 2006
- Status
- Private
- Employees
- 8
- Latest Deal Type
- Corporate
- Financing Rounds
- 1
Asklepion Pharmaceuticals General Information
Description
Operator of a pharmaceutical company engaged in the research and development. The company mainly focuses on different types of liver-based diseases.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Primary Office
- 729 East Pratt Street
- Suite 360
- Baltimore, MD 21202
- United States
+1 (410) 000-0000
Asklepion Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Asklepion Pharmaceuticals‘s full profile, request access.
Request a free trialAsklepion Pharmaceuticals Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gary Pasternack Ph.D | Chief Executive Officer | ||
| Kenneth Setchell Ph.D | Chief Scientific Officer | ||
| Gary Pyner Sr. | Chief Commercial Officer |
Asklepion Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAsklepion Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Asklepion Pharmaceuticals‘s full profile, request access.
Request a free trial